Skip to content

Biz News Today

Business News – Direct Source News

  • Home
  • Business News Videos
    • International/National News Videos
  • Directory
  • Links PRs
  • REITS
  • About
  • Contact
    • Sitemap

Bristol Myers Squibb Receives European Commission Approval for Onureg® (azacitidine tablets) as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia

  • Home
  • 2021
  • June
  • 18
  • Bristol Myers Squibb Receives European Commission Approval for Onureg® (azacitidine tablets) as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia

Original Source

On June 18, 2021

Post navigation

Previous PostEisai and Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai’s MORAb-202 Antibody Drug Conjugate
Next PostQorvo Advances Radar Architecture with Reconfigurable Dual-band GaN Power Amplifier MMICs

Related Post

May 27, 2022
  • Business News

U.S. Food and Drug Administration Approves Two Opdivo® (nivolumab)-Based Regimens as First-Line Treatments for Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma

May 27, 2022
  • Business News

NVIDIA Recommends Stockholders Reject ‘Mini-Tender’ Offer by Tutanota LLC

May 27, 2022
  • Business News

Quanta Services Announces Quarterly Cash Dividend

Copyright © All right reserved
Newslist Created By Rise Themes

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219